Literature DB >> 21068234

The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity.

Chi Ying Cheng1, Timra Gilson, Frédéric Dallaire, Gary Ketner, Philip E Branton, Paola Blanchette.   

Abstract

Although human adenovirus type 5 (Ad5) has been widely studied, relatively little work has been done with other human adenovirus serotypes. The Ad5 E4orf6 and E1B55K proteins form Cul5-based E3 ubiquitin ligase complexes to degrade p53, Mre11, DNA ligase IV, integrin α3, and almost certainly other targets, presumably to optimize the cellular environment for viral replication and perhaps to facilitate persistence or latency. As this complex is essential for the efficient replication of Ad5, we undertook a systematic analysis of the structure and function of corresponding E4orf6/E1B55K complexes from other serotypes to determine the importance of this E3 ligase throughout adenovirus evolution. E4orf6 and E1B55K coding sequences from serotypes representing all subgroups were cloned, and each pair was expressed and analyzed for their capacity to assemble the Cullin-based ligase complex and to degrade substrates following plasmid DNA transfection. The results indicated that all formed Cullin-based E3 ligase complexes but that heterogeneity in both structure and function existed. Whereas Cul5 was present in the complexes of some serotypes, others recruited primarily Cul2, and the Ad16 complex clearly bound both Cul2 and Cul5. There was also heterogeneity in substrate specificity. Whereas all serotypes tested appeared to degrade DNA ligase IV, complexes from some serotypes failed to degrade Mre11, p53, or integrin α3. Thus, a major evolutionary pressure for formation of the adenovirus ligase complex may lie in the degradation of DNA ligase IV; however, it seems possible that the degradation of as-yet-unidentified critical targets or, perhaps even more likely, appropriate combinations of substrates plays a central role for these adenoviruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21068234      PMCID: PMC3020000          DOI: 10.1128/JVI.01890-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53.

Authors:  Paola Blanchette; Chi Ying Cheng; Qin Yan; Gary Ketner; David A Ornelles; Thomas Dobner; Ronald C Conaway; Joan Weliky Conaway; Philip E Branton
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

2.  Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression.

Authors:  D H Weinberg; G Ketner
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport.

Authors:  L E Babiss; H S Ginsberg; J E Darnell
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

4.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

Authors:  P Sarnow; Y S Ho; J Williams; A J Levine
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

5.  Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff.

Authors:  D N Halbert; J R Cutt; T Shenk
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

6.  CD46 is a cellular receptor for group B adenoviruses.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; André Lieber
Journal:  Nat Med       Date:  2003-10-19       Impact factor: 53.440

7.  Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.

Authors:  P R Yew; A J Berk
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

8.  p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

Authors:  T Mitsudomi; S M Steinberg; M M Nau; D Carbone; D D'Amico; S Bodner; H K Oie; R I Linnoila; J L Mulshine; J D Minna
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

9.  Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery.

Authors:  Josephine N Harada; Anna Shevchenko; Andrej Shevchenko; David C Pallas; Arnold J Berk
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs.

Authors:  S Pilder; M Moore; J Logan; T Shenk
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

View more
  35 in total

1.  Serotype-specific inactivation of the cellular DNA damage response during adenovirus infection.

Authors:  Natalie A Forrester; Garry G Sedgwick; Anoushka Thomas; Andrew N Blackford; Thomas Speiseder; Thomas Dobner; Philip J Byrd; Grant S Stewart; Andrew S Turnell; Roger J A Grand
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

2.  Analysis of the Cullin binding sites of the E4orf6 proteins of human adenovirus E3 ubiquitin ligases.

Authors:  Timra Gilson; Chi Ying Cheng; Woosuk Steve Hur; Paola Blanchette; Philip E Branton
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

3.  Role of E1B55K in E4orf6/E1B55K E3 ligase complexes formed by different human adenovirus serotypes.

Authors:  Chi Ying Cheng; Timra Gilson; Peter Wimmer; Sabrina Schreiner; Gary Ketner; Thomas Dobner; Philip E Branton; Paola Blanchette
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

4.  Aggresome formation by the adenoviral protein E1B55K is not conserved among adenovirus species and is not required for efficient degradation of nuclear substrates.

Authors:  Paola Blanchette; Peter Wimmer; Frédéric Dallaire; Chi Ying Cheng; Philip E Branton
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

5.  Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.

Authors:  Heng Yang; Zhi Zheng; Lisa Y Zhao; Qiang Li; Daiqing Liao
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

6.  Human Adenovirus Infection Causes Cellular E3 Ubiquitin Ligase MKRN1 Degradation Involving the Viral Core Protein pVII.

Authors:  Raviteja Inturi; Kwangchol Mun; Katrin Singethan; Sabrina Schreiner; Tanel Punga
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

7.  Using the E4orf6-Based E3 Ubiquitin Ligase as a Tool To Analyze the Evolution of Adenoviruses.

Authors:  Timra Gilson; Paola Blanchette; Mónika Z Ballmann; Tibor Papp; Judit J Pénzes; Mária Benkő; Balázs Harrach; Philip E Branton
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

8.  Adenovirus E4orf3 targets transcriptional intermediary factor 1γ for proteasome-dependent degradation during infection.

Authors:  Natalie A Forrester; Rakesh N Patel; Thomas Speiseder; Peter Groitl; Garry G Sedgwick; Neil J Shimwell; Robert I Seed; Pól Ó Catnaigh; Christopher J McCabe; Grant S Stewart; Thomas Dobner; Roger J A Grand; Ashley Martin; Andrew S Turnell
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

Review 9.  Adenoviral strategies to overcome innate cellular responses to infection.

Authors:  Sook-Young Sohn; Patrick Hearing
Journal:  FEBS Lett       Date:  2019-11-26       Impact factor: 4.124

10.  Serotype-specific restriction of wild-type adenoviruses by the cellular Mre11-Rad50-Nbs1 complex.

Authors:  Neha J Pancholi; Matthew D Weitzman
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.